The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 168.00
Bid: 167.80
Ask: 168.00
Change: 3.60 (2.19%)
Spread: 0.20 (0.119%)
Open: 167.00
High: 168.20
Low: 165.40
Prev. Close: 164.40
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

27 Apr 2018 13:14

RNS Number : 4279M
Forterra plc
27 April 2018
 

27 April 2018

Forterra plc

PDMR Shareholdings

Forterra plc (the "Company") was notified on 26 April 2018 that on the same day Matthew Clay, Managing Director, Bespoke Products and Darren Rix, Strategy and Development Director both of whom are defined as Persons Discharging Management Responsibilities (PDMR's) exercised share options over the Company's ordinary shares of 1p each ("ordinary shares") granted under the Forterra Deferred Annual Bonus Plan.

The options were granted as nominal (1p) cost options although this sum was waived by the Company on exercise. The number of options exercised also includes a dividend equivalent in addition to the options initially granted in accordance with the rules of the scheme. On exercise, sufficient shares were immediately sold to cover tax, NI and transaction costs.

No new shares were issued in respect of these transactions with the shares being transferred to the individuals from the Forterra Employee Benefit Trust.

Name

Number of options exercised

Number of shares transferred to individual after paying tax, NI and transaction costs

Number of shares now beneficially held by individual

Matthew Clay

18,779

9,921

9,921

Darren Rix

11,768

6,217

6,217

 

 

Enquiries

 

Forterra plc:

+44 (0) 1604 707 600

Shatish Dasani (CFO)

Ben Guyatt (Company Secretary)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain/Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk.

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Matthew Clay

2.

Reason for the notification

a)

Position/status

Managing Director Bespoke Products (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 18,779 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 8,858 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (9,921) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

18,779

(ii) Sale

£3.06

8,858

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

18,779

Nil

 (ii) Sale

£3.06

8,858

£27,105.48

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Darren Rix

2.

Reason for the notification

a)

Position/status

Strategy and Development Director (PDMR)

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Forterra plc

b)

LEI

5299007SD2PDQMKM5278

4.

Details of the transaction(s):

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 1p each

 

GB00BYYW3C20

b)

Nature of the transaction

(i) Acquisition of 11,768 shares in the Company following the vesting of an award granted under the DABP on 1 June 2016; and (ii) subsequent sale of 5,551 shares to cover PAYE/NI liabilities arising from such vesting. The remainder of the shares (6,217) are being retained

c)

Price(s) and volume(s)

Transaction

Price(s)

Volume(s)

(i) Acquisition

Nil

11,768

(ii) Sale

£3.06

5,551

d)

Aggregated information

 

Transaction

Price(s)

Volume(s)

Total

 (i) Acquisition

Nil

11,768

Nil

 (ii) Sale

£3.06

5,551

£16,986.06

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGUCGCUPRGPM
Date   Source Headline
10th Dec 20197:00 amRNSBoard Changes
6th Dec 201910:46 amRNSDirector/PDMR Shareholding
4th Dec 201912:01 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 201912:38 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20199:51 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSTrading update
7th Oct 20192:03 pmRNSHolding(s) in Company
4th Oct 20192:09 pmRNSGrant of Options under 2018 SAYE Scheme
2nd Oct 20193:15 pmRNSEmployee Benefit Trust Share Purchase
26th Sep 20194:50 pmRNSEmployee Benefit Trust Share Purchase
9th Sep 20195:34 pmRNSDirector/PDMR Shareholding
4th Sep 20198:51 amRNSHolding(s) in Company
30th Jul 20197:00 amRNS2019 HALF YEAR RESULTS
4th Jul 201911:49 amRNSEmployee Benefit Trust Share Purchase
5th Jun 20199:20 amRNSEmployee Benefit Trust Share Purchase
20th May 20191:57 pmRNSResult of AGM
20th May 20197:00 amRNSAGM Trading Update
10th May 20193:08 pmRNSDirector/PDMR Shareholding
3rd May 20199:00 amRNSEmployee Benefit Trust Share Purchase
5th Apr 20192:50 pmRNSDirector/PDMR Shareholding
5th Apr 20192:49 pmRNSEmployee Benefit Trust Share Purchase
5th Apr 20191:21 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
2nd Apr 20193:58 pmRNSDirector/PDMR Shareholding
29th Mar 20199:11 amRNSGrant under Performance Share Plan
29th Mar 20199:10 amRNSGrant under Deferred Annual Bonus Plan
14th Mar 201911:28 amRNSEmployee Benefit Trust Share Purchase
12th Mar 201910:00 amRNSEmployee Benefit Trust Share Purchase
5th Mar 20198:45 amRNSEmployee Benefit Trust Share Purchase
8th Feb 20199:00 amRNSDirector Declaration
8th Feb 20197:00 amRNSAppointment of new Independent NED
6th Feb 20191:30 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20191:38 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20197:00 amRNSTrading Update
8th Jan 20199:27 amRNSEmployee Benefit Trust Share Purchase
19th Dec 201810:09 amRNSEmployee Benefit Trust Share Purchase
4th Dec 20182:27 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 201812:23 pmRNSHolding(s) in Company
20th Nov 201810:30 amRNSReplacement Director/PDMR Shareholding
20th Nov 20189:12 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSEmployee Benefit Trust Share Purchase
1st Nov 20187:00 amRNSTrading Update
17th Oct 20188:49 amRNSHolding(s) in Company
16th Oct 20182:51 pmRNSHolding(s) in Company
9th Oct 20189:34 amRNSDirector Declaration
5th Oct 20182:07 pmRNSEmployee Benefit Trust Share Purchase
4th Oct 20188:58 amRNSGrant of Options under 2018 SAYE Scheme
27th Sep 20181:37 pmRNSHolding(s) in Company
18th Sep 20184:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.